The integration of genomic testing into cancer screening enables diagnostics to break away from conventional, one-size-fits-all protocols.

MEN over 40 in Inverclyde have another opportunity to get a free prostate cancer test as McGill’s Buses continue their support for a nationwide screening initiative after "phenomenal demand". More ...

This is read by an automated voice. Please report any issues or inconsistencies here. A non-surgical facelift does not tighten loose skin or replicate surgery. It refines structure. That’s how Los ...

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

Created for all skin tones and types, the treatment collection aims to firm, smooth and resurface skin, the brand shared. The Olay Regenerist Treatments are now available nationwide at major retailers ...

A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...

Forbes contributors publish independent expert analyses and insights. A former tech executive covering AI, XR and The Metaverse for Forbes. At CES 2026, LumiMind presented its brand new closed-loop ...

Neurable and HyperX are teaming up to develop a gaming headset designed to help you play better. How will it do this? With an "industry-first neurotechnology-powered" headset that can potentially ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

SAN FRANCISCO--(BUSINESS WIRE)--Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, today announced the commercial launch of the ArteraAI Prostate Test (Post‑RP) for ...